TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 2 | 1 | 24 | 23 | -8 | 3 | -17 | 4 |
P | %wins | 50 | 50 | 100 | 50 | 50 | 50 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/20/11 15:56 | 9/16/11 | ZGNX | Zogenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Clarus Lifesciences I, L.P. | MA | T | P | 7,000 | 2.00 | 0 | 3,500 | 59 | 9,482 | I | -60 | -46 | -57 | -42 | -34 | -24 | -2 | -2 | 1 | -25 | -6 | 22 | |||
11/30/10 19:03 | 11/29/10 | ZGNX | Zogenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Clarus Lifesciences I, L.P. | MA | T | P.d | 7,000 | 4.00 | 0 | 1,750 | 41 | 5,982 | D | -2 | 4 | 50 | 44 | 10 | 12 | -55 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |